Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Neurochem. 2011 Nov 24;120(1):56–69. doi: 10.1111/j.1471-4159.2011.07559.x

Fig. 4. TX100 solubility of RGS9-2 and Gβ5 in mouse brain.

Fig. 4

A. Western blot (WB) of RGS9-2 in TX100 soluble (S) and insoluble (P, pellet) cell fractions from mouse cortex and striatum. B. Levels of RGS9-2 protein in TX100-soluble (closed black bars) and insoluble (open bars) striatal fractions visualized in A and expressed as percentage of the total striatal RGS9-2 signal (mean ± SEM, n=4, *represents p<0.01 compared to RGS9-2 protein signal in the TX100 soluble fraction). C. Western blot (WB) of Gβ5 in TX100 soluble (S) and insoluble (P, pellet) cell fractions from mouse cortex and striatum. D. Levels of Gβ5 protein in TX100-soluble (closed black bars) and insoluble (open bars) cellular fractions visualized in C and expressed as percentage of the total detected Gβ5 protein signal detected, respectively, in mouse cortex and striatum (mean ± SEM, n=4, *represents p<0.01 compared to Gβ5 protein signal in the TX100 insoluble fraction from the cortex).